O.) 432441 (Karger, 2007)
MS-DRG assignment for inpatient DM admissions (DKA, HHS, hypoglycemia) is driven by principal diagnosis ensure the acute complication is sequenced appropriately as PDx when it is the reason for admission

Aqua/Water, Polyvinyl Alcohol, Octyldodecanol, Methylpropanediol, Butylene Glycol, Niacinamide, Caprylic/Capric Triglyceride, 1,2-Hexanediol, Algin, Polysorbate 80, Pentaerythrityl Tetraethylhexanoate, Pullulan, Simmondsia Chinensis (Jojoba) Seed Oil, Polyglyceryl-10 Oleate, Glyceryl Stearate, PEG-100 Stearate, Titanium Dioxide, Disteardimonium Hectorite, Synthetic Fluorphlogopite, Mica, Microcrystalline Cellulose, Ethylhexylglycerin, Sphingomonas Ferment Extract, Adenosine, Cellulose Gum, Sodium Phytate, Sodium DNA, Tin Oxide, Glutathione, Acetyl Glucosamine, Allantoin, Panthenol, Hydrolyzed Collagen, Gluconolactone, Mannitol, Centella Asiatica Leaf Extract, Glycerin, Lactobacillus Extracellular Vesicles, Hydrated Silica, Citric Acid, Sodium Hyaluronate, Caprylyl Glycol, Acetyl Hexapeptide-8

It is estimated that 170 million of people worldwide are infected with the hepatitis C virus (HCV).1 In Mexico HCV prevalence for the general population is 1.4%2 but in some risk populations the prevalence is higher.3,4 Although only a small proportion of acute HCV infections are symptomatic, hepatitis C progresses to chronic infection in approximately 60-85% of cases,2,5,6 and 15 to 20% of HCV chronically infected patients develop liver cirrhosis after 20 years, while 1-4% will develop hepatocellular carcinoma (HCC).7,8 In the Mexican population chronic liver diseases represent the fourth leading cause of death and the second among productive-aged population.8 HCV is an RNA virus and a member of the Hepacivirus genus classified into the Flaviviridae family